Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proline plus gliflozin in type 2 diabetes with early renal ultrafiltration injury (Anhui diabetic nephropathy cohort)
ChiCTR2500114340Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wannan Medical College
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Proline in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis and glomerular hyperfiltration, sponsored by The First Affiliated Hospital of Wannan Medical College. Primary endpoints: Glomerular filtration rate and Blood glucose. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Proline
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosisglomerular hyperfiltration
Beyond the preview
Go deeper on ChiCTR2500114340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114340.